Structural Magnetic Resonance Imaging (sMRI) provides information on brain atrophy patterns, while Positron Emission Tomography (PET) can detect metabolic changes and specific molecular pathologies like amyloid-beta and tau deposits [11, 12]. Here, MAPT is linked to Brain atrophy.